Quantcast

Industry news that matters to you.  Learn more

Archives for September 2011

Webinar: The New Face of Personalized Medicine, Targeting Disease Diagnostics and Treatments with Big Data Analytics

Thanks to incredible progress in technology development and biomedical research, we have more preventive, diagnostic and treatment alternatives for human diseases than ever before. However, we still don’t know what works in healthcare and for which patients. On October 6th, join Bio-IT World Editor-in-Chief Kevin Davies, Ph.D., for an interactive webinar discussion on The New Face of Personalized Medicine: Targeting Disease Diagnostics and Treatments with Big Data Analytics.

NYAS Symposium: Biomarkers and Brain Imaging of Presymptomatic Alzheimer’s Disease

The New York Academy of Sciences (NYAS) will be holding an afternoon event in January 2012 that focuses on biomarkers and brain imaging of presymptomatic Alzheimer’s disease. Biomarkers and Brain Imaging of Presymptomatic Alzheimer’s Disease: Exploring the Silent Years will be held on Tuesday, January 24th, from 1pm – 5pm EST (10am – 2pm PST).

Study Examines Blood Biomarkers Upon Erythropoietin Treatment of Ischemic Stroke

Researchers at the Max Planck Institute of Experimental Medicine in Goettingen, Germany, led by Prof. Hannelore Ehrenreich, the University of Bremen and University of Hannover, in collaboration with Dr. Andreas Jeromin at Banyan Biomarkers, Inc, in Alachua, FL, have identified a panel of protein-based blood biomarkers in patients treated with erythropoietin (EPO), which correlate with positive outcome in this study.

Health Discovery Corporation Announces Issuance of First Patent Covering Prostate Cancer Biomarkers

Health Discovery Corporation is pleased to announce that the United States Patent and Trademark Office has issued the first of what the Company expects to be several patents covering methods to screen for the presence of prostate cancer using genomic biomarkers that were identified by HDC researchers using the Company’s patented RFE-SVM algorithm.

NIH to Support Clinical Trial Implementation or Biomarker Clinical Evaluation Studies

Earlier this month, the National Institutes of Health announced that the National Institute of Dental and Craniofacial Research (NIDCR) Institute will support mission-relevant investigator-initiated Phase I, II, III or IV clinical trial cooperative agreement applications or biomarker evaluation studies that require prospective collection of clinical outcomes and clinical specimens.